Clinical Trial Update: A Phase 2 Study of D-2570 in Subjects With Moderately to Severely Active Ulcerative Colitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating D-2570 in adults with moderately to severely active ulcerative colitis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• D-2570

Snippet

Sponsor: InventisBio Co., Ltd | Conditions: UC - Ulcerative Colitis, Moderately to Severely Active Ulcerative Colitis | Phase 2 | Status: RECRUITING